Amikacin Sulfate

Records for this ingredient, by country (identity only).

ATC — · 3 markets · 19 records

Amikacin Sulfate 3 markets · 19 records Forms
Filters
MarketAU 12FR 6SG 1

AU 12 records · 9 shown of 9 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 667.5 mg per mL / per unit basis not statedinjectionAMIKACIN DEMOGEN amikacin (as sulfate) 1000 mg/4 mL solution for injection ampouleAMIKACIN EMC amikacin (as sulfate) 500 mg/2 mL solution for injection vial unknown
  • 667.6 mg per mL / per unit basis not statedinjectionAMIKACIN MEDICIANZ amikacin (as sulfate) 500 mg/2 mL solution for injection vialAMIKACIN MEDSURGE amikacin (as sulfate) 500 mg/2 mL solution for injection vial unknown
  • 333.76 mg/mL per mL / per unit basis not statedinjectionAMIKACIN WOCKHARDT amikacin (as sulfate) 500mg/2mL solution for injection infusion vialAMIWOK amikacin (as sulfate) 500mg/2mL solution for injection infusion vial unknown
  • 1,336 mg per mL / per unit basis not statedliquidAMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle unknown
  • 668 mg per mL / per unit basis not statedliquidAMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle unknown
  • 334 mg per mL / per unit basis not statedliquidAMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle unknown
  • 1,335 mg per mL / per unit basis not statedinjectionAMIKACIN DEMOGEN amikacin (as sulfate) 1000 mg/4 mL solution for injection ampoule unknown
  • 333.75 mg per mL / per unit basis not statedinjectionAMIKACIN DEMOGEN amikacin (as sulfate) 1000 mg/4 mL solution for injection ampoule unknown
  • 333.65 mg/mL per mL / per unit basis not statedinjectionHospira Amikacin 250 mg/mL Injection 500 mg/2 mL vial unknown

FR 6 records · 6 shown of 6 Source Base de données publique des médic · Data as of 2026-11-03

  • 667.5 mg per mL / per unit basis not statedinjectionAMIKACINE VIATRIS 250 mg, poudre pour solution injectable
  • 1000 mg per mL / per unit basis not statedinjectionAMIKACINE VIATRIS 1 g, poudre pour solution injectable en flacon
  • 333.7 mg per mL / per unit basis not statedinjectionAMIKACINE VIATRIS 250 mg, poudre pour solution injectable
  • 250 mg per mL / per unit basis not statedinjectionAMIKACINE PANPHARMA 250 mg/mL, solution injectable
  • 66.75 mg per mL / per unit basis not statedinjectionAMIKACINE VIATRIS 50 mg/1 ml, solution injectable
  • 590 mginhalationARIKAYCE LIPOSOMAL 590 mg, dispersion pour inhalation par nébuliseur

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 500 mg/2 mLinjectionILDONG AMIKACIN INJECTION 500 mg/2 ml

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.